CJM Wealth Advisers’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$910K Buy
786
+56
+8% +$66.1K 0.24% 39
2026
Q2
$876K Buy
730
+9
+1% +$9.2K 0.23% 38
2026
Q1
$663K Buy
721
+14
+2% +$14.2K 0.2% 38
2025
Q4
$760K Sell
707
-5
-0.7% -$4.78K 0.23% 35
2025
Q3
$543K Buy
712
+5
+0.7% +$3.72K 0.17% 45
2025
Q2
$551K Hold
707
– – 0.18% 40
2025
Q1
$584K Hold
707
– – 0.21% 36
2024
Q4
$546K Sell
707
-25
-3% -$20.7K 0.18% 37
2024
Q3
$649K Buy
+732
New +$658K 0.22% 33

Other funds holding LLY

CJM Wealth Advisers's LLY Position: Q3 2026 in Review

CJM Wealth Advisers increased its Eli Lilly (LLY) stake by 7.7% in Q3 2026, buying an estimated $66.1K and bringing the position to 786 shares worth $910K. The position accounts for 0.24% of the portfolio, ranked #39.

CJM Wealth Advisers first reported a position in LLY in Q3 2024 and has held it in 9 quarters since. 3,244 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • CJM Wealth Advisers held 786 shares of Eli Lilly worth $910K as of Q3 2026.
  • CJM Wealth Advisers bought 56 Eli Lilly shares in Q3 2026, an estimated $66.1K.
  • Eli Lilly made up 0.24% of CJM Wealth Advisers's portfolio in Q3 2026, its #39 holding.
  • CJM Wealth Advisers first reported a position in Eli Lilly in Q3 2024 and has held it in 9 quarters since.
  • 3,244 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on CJM Wealth Advisers's 13F filing for Q3 2026, filed 27 Oct 2026.